Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-22-017977

SVP of Research, CSO sold 3,227 shares at $1.09 ($3,517)

From the SEC's structured data for this filing

Trades in this filing

Magnani John L. · SVP of Research, CSO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-09 Sale : show line 1 in the form −3,227 $1.09 $3,517 321,033 D
Open-market sales · 3,227 sh · avg $1.09 · $3,517
Loading xslF345X03/doc4.xml…